Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2005
12/07/2005CN1230182C Method for preventing and reversing atherosclerosis in mammals
12/07/2005CN1230096C Process for preparing iron-containing soy
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972321 Monomeric protein of the TGF-β family
12/06/2005US6972282 Process for producing a product containing antihypertensive tripeptides
12/06/2005US6972194 culturing cells in envelopes comprising acrylic amide homopolymers, for use in immunization against tumor cells and prophylaxis of diabetes; vaccines
12/06/2005US6972168 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture
12/06/2005US6972128 allogeneic immunotherapy; vaccines; immortalization
12/06/2005CA2208274C Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
12/01/2005WO2005113780A1 Adipose-derived stem cells and lattices
12/01/2005WO2005113754A1 Pluripotent adult stem cells
12/01/2005WO2005113752A2 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
12/01/2005WO2005113748A2 Mapc generation of lung tissue
12/01/2005WO2005113747A2 Multicellular tissue and organ culture systems
12/01/2005WO2005113743A2 Device for carrying out a liquid/air culture of epithelium
12/01/2005WO2005113018A2 Cancer treatment using viruses and camptothecins
12/01/2005WO2005113014A1 siRNA TO VP-1 OF JC VIRUS AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/01/2005WO2005113013A2 Compositions of ndv and methods of use thereof for treatment of cancer
12/01/2005WO2005113005A2 Transcutaneous and/or transdermal transport of materials
12/01/2005WO2005112976A2 Probiotic compounds from lactobacillus gg and uses therefor
12/01/2005WO2005112966A1 Combined therapy with a herbal extract and a reovirus for killing neoplastic cells in a subject
12/01/2005WO2005112964A1 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
12/01/2005WO2005112961A1 The use of a replication competent virus or its recombinant in therapy
12/01/2005WO2005112960A1 Treatment for asthma and arthritis and othe inflammatory diseases
12/01/2005WO2005112959A2 Use of umbilical cord blood stem cells to treat ischemic event
12/01/2005WO2005112955A1 A composition for prevention and treatment of colon adenomas
12/01/2005WO2005112910A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
12/01/2005WO2005112881A1 The dispersible montmorillonite tablet and its preparation technology
12/01/2005WO2005112877A1 Scalp and hair-care composition
12/01/2005WO2005112658A1 Method and composition for reducing e. coli disease and enhancing performance using bacillus
12/01/2005WO2005086781A3 Regulatory t cells and their use in immunotherapy and suppression of autoimmune responses
12/01/2005WO2005051330B1 METHOD FOR TREATING HUMAN TUMOR CELLS WITH A NEWCASTLE DISEASE VIRUS STRAIN HAVING A p53 INDEPENDENT ONCOLYTIC EFFECT
12/01/2005WO2005009460A3 Pharmaceutical composition comprising activin a, alk-4 or derivatives thereof for the treatment of ophthalmic disorders or cancer
12/01/2005WO2004094988A3 Tolerance to graft prior to thymic regeneration
12/01/2005WO2004094649A3 Tolerance to graft following thymic reactivation
12/01/2005WO2003102134A3 Pancreatic acinar cells into insulin producing cells
12/01/2005WO2003049703A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
12/01/2005US20050267027 Use of erythropoietin for treatment of cancer
12/01/2005US20050267020 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same
12/01/2005US20050266556 Isolation, expansion and use of clonogenic endothelial progenitor cells
12/01/2005US20050266549 Molecular switch for regulating mammalian gene expression
12/01/2005US20050266545 Lactic acid bacteria with immunoregualting activites
12/01/2005US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders
12/01/2005US20050266532 Albumin fusion proteins
12/01/2005US20050266107 Administering mixture of flavopereirine and alstonine for preventing prostate cancer and/or reducing PSA levels and/or alleviating the symptoms of BPH (Benign Prostatic Hyperplasia) or PIN (prostatic intraepithelial neoplasia)
12/01/2005US20050266094 Topical composition and method for the treatment and prophylaxis of dermal irritations
12/01/2005US20050266081 Antimicrobial silver hydrogels
12/01/2005US20050266069 Stable probiotic microsphere compositions and their methods of preparation
12/01/2005US20050266037 Implantable biomaterial and method for the preparation thereof
12/01/2005US20050266035 Skin protectant spray compositions
12/01/2005US20050265989 Non-toxic purification and activation of prothrombin and use thereof
12/01/2005US20050265984 Weak assimilating activity or no assimilating activity for glycerol; beneficial bioactivities such as an intestine regulating activity and immunostimulating activity
12/01/2005US20050265982 cells cultured in serum, antibiotics, cell growth factors and epinephrine, exhibiting cell proliferation, migration and melanin production, used for treating skin disorders
12/01/2005US20050265981 Transdifferentiation of glial cells
12/01/2005US20050265977 living cells collected from the choroid plexus of a mammal containing some choroid epithelial cells; implant secretes at least one product that has a beneficial effect on a neurological disease when transplanted into a recipient mammal suffering from such neurological disease
12/01/2005US20050265976 Method of differentiation of morula or inner cell mass cells and method of making lineage-defective embryonic stem cells
12/01/2005US20050265973 Chimeric adenoviruses for use in cancer treatment
12/01/2005US20050265971 Agent for treatment of breast cancer and pancreatic cancer comprising herpes simplex virus mutant
12/01/2005DE10328669B4 Plasmidfreier Klon des E. coli Stammes DSM 6601 Plasmid-free clone of E. coli strain DSM 6601
12/01/2005DE102004023612A1 Use of microbial mixed biocoenosis comprising photosynthetic bacteria, actinomycete, lactic acid bacteria, yeast or ferment active fungus, for treating skin inflammations and dermatitis
12/01/2005CA2841716A1 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
12/01/2005CA2578549A1 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
12/01/2005CA2567190A1 Combinations of hyaluronic acid and polyunsaturated fatty acids
12/01/2005CA2567189A1 Treatment for asthma and arthritis and other inflammatory diseases
12/01/2005CA2566857A1 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells
12/01/2005CA2566617A1 Method and composition for reducing e.coli disease and enhancing performance using bacillus
12/01/2005CA2566363A1 High affinity ny-eso t cell receptor
12/01/2005CA2564652A1 Mapc generation of lung tissue
12/01/2005CA2564466A1 Method of preparation and use of fibrinolytic enzymes in the treatment of disease
12/01/2005CA2563702A1 Probiotic compounds from lactobacillus gg and uses therefor
12/01/2005CA2562904A1 Cancer treatment using viruses and camptothecins
11/2005
11/30/2005EP1600502A1 Human salivary gland-origin stem cell
11/30/2005EP1600501A1 Use of lif for tissue and cellular engineering
11/30/2005EP1600163A1 Use of the neurotoxic component of botulinum toxins for the treatment of spastic muscle
11/30/2005EP1600152A1 Use of LIF in cosmetics and dermatology
11/30/2005EP1599715A2 Autologous or homologous coagulant produced from anticoagulated whole blood
11/30/2005EP1599575A2 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
11/30/2005EP1599237A1 Method for cleaning a bone-graft material
11/30/2005EP1599227A2 Methods of immunomodulation in animals
11/30/2005EP1599128A2 Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
11/30/2005EP1461440A4 Cultured cells from pancreatic islets
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1185306B1 Use of viral vectors and charged molecules for gene therapy
11/30/2005EP1178740B1 Sports drink comprising micronutrients and viable lactobacilli
11/30/2005EP1140010B1 Composition and method of sequestration of skin irritants.
11/30/2005EP0808364B1 Human pancreatic cell lines: developments and uses
11/30/2005CN1703508A Tailor-made multifunctional stem cells and utilization thereof
11/30/2005CN1703506A Procedure for the large-scale t-lymphocytes culture in a homogeneous system
11/30/2005CN1703505A A method of treating an autoimmune disease
11/30/2005CN1703259A Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof
11/30/2005CN1703175A Implantation of encapsulated biological materials for treating diseases
11/30/2005CN1701796A Chinese medicinal preparation with viral infection resisting function
11/30/2005CN1229501C Mixture of recombinant vaccinia vectors as poly-envelope protein vaccines for HIV
11/30/2005CN1229382C Hemisynthetic method and intermediate thereof
11/30/2005CN1229117C Hircus treating medicament
11/29/2005US6969609 nucleic acid sequences encoding a combination of B7, ICAM-1 and LFA-3, wherein expression of the nucleic acid sequences occurs in the host cel
11/29/2005US6969608 Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors
11/29/2005US6969532 Compounds inhibiting COX-2 and iNOS promoter activities
11/29/2005US6969518 Compositions and methods for the therapy and diagnosis of breast cancer
11/26/2005CA2503105A1 Use of lif in cosmetics and dermatology
1 ... 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 ... 1259